rs7540883

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_213653.4(HJV):​c.929C>G​(p.Ala310Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00392 in 1,614,126 control chromosomes in the GnomAD database, including 194 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A310D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.021 ( 105 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 89 hom. )

Consequence

HJV
NM_213653.4 missense

Scores

3
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.51

Publications

17 publications found
Variant links:
Genes affected
HJV (HGNC:4887): (hemojuvelin BMP co-receptor) The product of this gene is involved in iron metabolism. It may be a component of the signaling pathway which activates hepcidin or it may act as a modulator of hepcidin expression. It could also represent the cellular receptor for hepcidin. Two uORFs in the 5' UTR negatively regulate the expression and activity of the encoded protein. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. Defects in this gene are the cause of hemochromatosis type 2A, also called juvenile hemochromatosis (JH). JH is an early-onset autosomal recessive disorder due to severe iron overload resulting in hypogonadotrophic hypogonadism, hepatic fibrosis or cirrhosis and cardiomyopathy, occurring typically before age of 30. [provided by RefSeq, Oct 2015]
HJV Gene-Disease associations (from GenCC):
  • hemochromatosis type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • hemochromatosis type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012807339).
BP6
Variant 1-146018429-G-C is Benign according to our data. Variant chr1-146018429-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 292430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HJVNM_213653.4 linkc.929C>G p.Ala310Gly missense_variant Exon 4 of 4 ENST00000336751.11 NP_998818.1 Q6ZVN8-1A0A024R4F5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HJVENST00000336751.11 linkc.929C>G p.Ala310Gly missense_variant Exon 4 of 4 2 NM_213653.4 ENSP00000337014.5 Q6ZVN8-1

Frequencies

GnomAD3 genomes
AF:
0.0212
AC:
3219
AN:
152184
Hom.:
105
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0739
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00752
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.00565
AC:
1421
AN:
251410
AF XY:
0.00404
show subpopulations
Gnomad AFR exome
AF:
0.0783
Gnomad AMR exome
AF:
0.00289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00212
AC:
3103
AN:
1461824
Hom.:
89
Cov.:
32
AF XY:
0.00187
AC XY:
1363
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.0748
AC:
2504
AN:
33480
American (AMR)
AF:
0.00369
AC:
165
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00676
AC:
39
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000935
AC:
104
AN:
1112010
Other (OTH)
AF:
0.00440
AC:
266
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0211
AC:
3219
AN:
152302
Hom.:
105
Cov.:
32
AF XY:
0.0206
AC XY:
1536
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0737
AC:
3063
AN:
41550
American (AMR)
AF:
0.00745
AC:
114
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68020
Other (OTH)
AF:
0.00946
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
143
286
430
573
716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00301
Hom.:
7
Bravo
AF:
0.0235
Asia WGS
AF:
0.00289
AC:
11
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 2A Benign:2
Dec 04, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;.;T;.;.
LIST_S2
Uncertain
0.92
.;.;D;D;D
MetaRNN
Benign
0.013
T;T;T;T;T
PhyloP100
2.5
PROVEAN
Benign
-0.87
N;N;N;N;.
Sift
Benign
0.19
T;T;T;T;.
Sift4G
Benign
0.13
T;T;T;T;.
Vest4
0.053
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7540883; hg19: chr1-145416584; API